David is CEO of The Bruckner Group, working with leading executives in the biotechnology, pharmaceutical, and medical device industries. Under his leadership, Bruckner has become the industry's leading expert in healthcare value strategy and payer strategy. Bruckner has developed substantial intellectual property and solves an unprecedented payer problem in the industry, consistently producing healthcare value and payer access results for clients.
Michael has twenty years of experience across nearly all aspects of biomedical and clinical research, product development, and commercialization. His diverse background unusually bridges the scientific, medical, and business worlds of healthcare, allowing for cross-disciplinary insights and creative strategic approaches to the problems faced by biopharma and device industry executives, private equity, and venture capital.
105 Central Street, Suite 4200 / Stoneham, MA 02180